Literature DB >> 3050072

Concurrence of ovarian cancer and dermatomyositis. A report of two cases and literature review.

N Mordel1, E J Margalioth, N Harats, N Ben-Baruch, J G Schenker.   

Abstract

The concurrence of dermatomyositis and ovarian carcinoma deserves special attention owing to the gravity of its prognosis. Until now, only scattered case reports on women suffering from this disease combination had been published. In this paper the information available in the literature on 28 women afflicted with these diseases is collated. In addition, two such patients treated in our hospital are described in detail. The review highlights the various aspects of this disease combination, emphasizing the quadrupled incidence, advanced stage and uniform epithelial origin of the malignancy as compared with that in the general female population with ovarian carcinoma. The value of a meticulous gynecologic evaluation was proven in one of our patients with dermatomyositis; in her, ovarian carcinoma was detected in its early phase.

Entities:  

Mesh:

Year:  1988        PMID: 3050072

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

Review 1.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

2.  Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.

Authors:  Yi-Ju Chen; Chun-Ying Wu; Yu-Lin Huang; Chang-Bi Wang; Jui-Lung Shen; Yun-Ting Chang
Journal:  Arthritis Res Ther       Date:  2010-04-16       Impact factor: 5.156

3.  [Dermatomyositis in the elderly: a study of 4 cases in southern Tunisia].

Authors:  Faten Frikha; Mouna Snoussi; Raida Ben Salah; Noura Saidi; Neila Kaddour; Zouhir Bahloul
Journal:  Pan Afr Med J       Date:  2012-10-06

Review 4.  Malignancy in patients with inflammatory myopathy.

Authors:  Rachelle Buchbinder; Catherine L Hill
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.686

5.  Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.

Authors:  Yao-Fan Fang; Yeong-Jian Jan Wu; Chang-Fu Kuo; Shue-Fen Luo; Kuang-Hui Yu
Journal:  Clin Rheumatol       Date:  2016-05-23       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.